Quantification of SARS-CoV-2 spike and nucleocapsid proteins using isotope dilution tandem mass spectrometry. Issue 36 (23rd August 2021)

• Record Type: Journal Article
• Authors: Pierce-Ruiz, Carrie; Santana, Wanda I.; Sutton, William J.H.; Fischler, David A.; Cooper, Hans C.; Marc, Lidoshka R.; Barr, John R.; Williams, Tracie L.
• Is Part Of: Vaccine. Volume 39:Issue 36(2021)
• Page Start: 5106
• Page End: 5115
• Publication Date: 2021-08-23
• Subjects: Coronavirus -- COVID-19 -- SARS-CoV-2 -- Mass spectrometry -- Spike -- Nucleocapsid -- Quantification -- Epidemic -- Pandemic -- Outbreak -- Vaccine; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2021.07.066
• Languages: English
• ISSNs: 0264-410X

Abstract

Abstract: The emergence and subsequent global outbreak of the novel coronavirus SARS-CoV-2 prompted our laboratory to launch efforts to develop methods for SARS-CoV-2 antigen detection and quantification. We present an isotope dilution mass spectrometry method (IDMS) for rapid and accurate quantification of the primary antigens, spike and nucleocapsid proteins. This IDMS method utilizes liquid chromatography-tandem mass spectrometry (LC-MS/MS) to analyze sample tryptic digests for detection and quantification of selected conserved peptides of SARS-CoV-2 spike and nucleocapsid proteins. The IDMS method has the necessary attributes to be successfully utilized for accurate quantification in SARS-CoV-2 protein-based vaccines and as targets of rapid diagnostic tests. Absolute quantification was achieved by quantifying and averaging 5 peptides for spike protein (3 peptides in the S1 subunit and 2 peptides in the S2 subunit) and 4 peptides for nucleocapsid protein. The overall relative standard deviation of the method was 3.67% for spike protein and 5.11% for nucleocapsid protein. IDMS offers speed (5 h total analysis time), sensitivity (LOQ; 10 fmol/µL) and precision for quantification of SARS-CoV-2 spike and nucleocapsid proteins.